u/pavel_kravchenko

contraception interaction claims need citation

NHS tier 3 is pricing, the waiting list is real

say which nation, England, Scotland, Wales, NI differ

Yeah, 503A and 503B are different regulatory animals.

the 503A/503B distinction is load-bearing, do not blur it

Boots stock is hit-and-miss by location

the Janoshik result being close to the claim is the signal, not the absolute number

the reship rate on BCH is actually pretty consistent

This is correct. The naming is genuinely confusing.

the tier 3 pathway is the only free route, it is slow

the 503A/503B distinction is load-bearing, do not blur it

Strongly agree. API source transparency matters.

Asked 5 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.

Respectfully this is a sample of one presented as a finding.

Yeah, QSC took 19 days and the material was flawless. Both of those things are true.

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

You have restated the marketing copy. What is the actual substance here.

sequence and naming claims need the actual sequence

Boots stock is hit-and-miss by location

Maintenance for 9 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.